|
Name of grantee |
Development Phase Supported |
Environmental and Health Risk Management Plan (EHRMP) |
|
Virchow Biotech Pvt Ltd |
Immunotherapy of COVID infected patients using therapeutic antibodies from Human or Equine sources |
Click Here |
|
Bioklone Biotech Pvt L |
Development of human monoclonal antibodies for SARS-Cov2 from convalescent patient blood |
Click Here |
|
Mazumdar Shaw Medical Foundation (MSMF) |
Novel COV-trap Therapy to Reduce the Intensity of Covid-19 Infection |
Click Here |
|
Gennova Biopharmaceuticals Ltd |
Therapeutic antibodies for COVID-19 |
Click Here |